Knight Therapeutics

Knight Therapeutics Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or licensing innovative pharmaceuticals for the Canadian and global markets. Knight Therapeutics' stock began trading on the TSX-V on March 3, 2014, under the symbol GUD.